Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: Examination of the characteristics of long-term survivors among patients with gallbladder cancer with liver metastasis who underwent surgical treatment: a retrospective multicenter study (ACRoS1406)

Fig. 2

Overall survival due to liver metastasis in stage III/IV gallbladder cancer patients without peritoneal dissemination or jaundice. Median survival times for H0, H1, H2, and unresected were 33, not reached, 9.0, and 6.8 months, respectively. *< 0.001, H0, no liver metastasis; H1, one liver metastasis; H2, two or more liver metastasis, No at risk, number at risk

Back to article page